Welcome to our dedicated page for BlackRock ESG Capital Allocation Term Trust SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock ESG Capital Allocation Term Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock ESG Capital Allocation Term Trust's regulatory disclosures and financial reporting.
BlackRock ESG Capital Allocation Term Trust (ECAT) reported insider activity from a 10% owner. Saba Capital Management, L.P. filed a Form 4 showing open-market sales of ECAT common stock. The filing lists 1,200 shares sold at $16.64 on October 28, 2025 and 75,953 shares sold at $16.55 on October 29, 2025. Following these transactions, Saba reported 27,400,370 shares beneficially owned, held indirectly.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling 25,802 common shares at $16.53 on 10/27/2025. After the sale, the reporting person beneficially owned 27,477,523 shares, held indirectly. The transaction was coded “S”, indicating a sale.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of 26,032 shares of common stock on 10/23/2025 at $16.32 per share (transaction code S).
Following the transaction, Saba Capital beneficially owned 27,503,325 shares, reported as indirect ownership. The filing was made by Saba Capital Management, L.P. and signed by representatives including Zachary Gindes and Boaz Weinstein.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of 28,112 common shares at $16.25 on 10/22/2025 (Transaction Code S).
After this trade, the reporting person lists 27,529,357 shares beneficially owned on an indirect basis.
Saba Capital Management, L.P., a reporting person in BlackRock ESG Capital Allocation Term Trust (ECAT), filed a Form 4 disclosing an open-market sale. On 10/16/2025, the reporting person sold 3,620 common shares at $16.22 per share.
Following the transaction, the filing lists 27,557,469 shares beneficially owned, held on an indirect basis. The relationship to the issuer is marked as Director and 10% Owner. This is an ownership update and does not reflect company operations or financial results.
Saba Capital Management, a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), filed a Form 4 reporting open-market sales. On 10/14/2025, it sold 50,936 common shares at $16.53. On 10/15/2025, it sold 6,233 common shares at $16.26. Following these transactions, indirect beneficial ownership was reported as 27,561,089 shares.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open‑market sales of common shares over three dates. The transactions were: 13,647 shares at $16.62 on 10/09/2025, 26,858 shares at $16.59 on 10/10/2025, and 19,408 shares at $16.58 on 10/13/2025. Following these sales, Saba reported 27,618,258 shares beneficially owned indirectly.
Saba Capital Management, L.P. reported an insider sale of $16.64 per share for 32,386 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) on 10/08/2025. After the sale the reporting person(s) beneficially own 27,678,171 shares indirectly. The Form 4 was signed on 10/09/2025 by Saba representatives.
Saba Capital Management, L.P., a reporting person affiliated with director status, disclosed two open‑market sales of Common Stock of BlackRock ESG Capital Allocation Term Trust (ECAT). On 10/06/2025 it sold 5,792 shares at $16.65, and on 10/07/2025 it sold 30,072 shares at $16.57. After these transactions the report shows 27,710,557 shares beneficially owned indirectly.
The Form 4 is signed by representatives with dates of signature on 10/08/2025. The filing indicates routine Section 16 reporting of insider sales; no derivative transactions or additional explanatory text are provided.
Saba Capital Management, L.P. reported insider transactions in BlackRock ESG Capital Allocation Term Trust (ECAT). The filing shows two open‑market sales: 5,524 shares sold on 10/02/2025 at $16.56 and 30,649 shares sold on 10/03/2025 at $16.65, totaling 36,173 shares disposed. After these sales, Saba reports an indirect beneficial ownership of 27,746,421 shares. The Form 4 is signed by authorized representatives of Saba on 10/06/2025.